Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    Company News

      India’s Nath Seeds Ties up with Chinese Biotech Firm for Bt Cotton.

      Japan’s Takara Grants Molmed Right to Use RetroNectin for Gene Therapy.

      Sumitomo to Access LifeSpan’s GPCR Expression and Localization Database.

      Wyeth Lederle Japan Transfers Over-the-counter Drugs to Takeda.

      Kyowa Hakko Develops New Antibody Technology.

      Australia’s BTF Completes Prototype for Precise Culture Based Microorganisms.

      Novogen to Start Phenoxodiol Clinical Trials in Australia.

      China Investigates Fault in US-made Tempo Pacemakers.

      Japan Drugmakers to Boost Sales in China.

      YuHan at Forefront of Pharmaceuticals in Korea.

      Eli Lilly Opens Asian Headquarters in Hong Kong.

      DSM Produces Semi-synthetic Penicillin in China.

      World Diagnostics to Sell Test Kits in India and Vietnam.

      AMDL Reports Disappointing Sales from Asian Distributor.

      Taiwan University and AbGenomics to Develop Proprietary Biomedical Platforms.

      Omeros Medical Systems and Singapore Institute to Develop New Drug Delivery System.

    • articleNo Access

      Trends & Prospects

        Foreign Drug Makers Face Expansion Bottleneck in China.

      • articleNo Access

        Company News

          Progen’s Anti-cancer Drug Shows Promising Human Trial Data.

          Acrux Reports Progress for Treatment of Female Sexual Dysfunction.

          Clinical Reagent Ready for Agenix’s Blood Clot Imaging Project.

          Austcancer’s Vaccine Human Trials Show Strong Results.

          Shanghai Desano to Sell Domestically Produced AIDS Drug.

          Shanghai Boxing Develops Bio Chip that Identifies GM Plants.

          Ranbaxy In-licenses New Biological Entity for Brain Cancer.

          Wockhardt and Daiichi in Collaboration for Hemorrhage Drug.

          Nicholas Piramal to Merge with Global Drugs.

          Shionogi in Agreement with Pharmagene for Target and Compound Validation Capabilities.

          Eisai’s Treatment of H. pylori Infection Approved by US.

          Tanabe Seiyaku and Altana in Roflumilast Cooperation in Japan.

          In2Gen Co. Ltd.

          InBioNET Corp.

          Agriquality Buys out Melbourne Gene Lab.

          Singapore Consulting Practice Brings Biomedical Firms to Asia.

          A-Bio Pharma is Singapore’s First Commercial Scale Biologics Manufacturer.

          Abbott and MerLion in Drug Discovery Collaboration.

          Lilly Systems Biology Research Center Established in Singapore.

        • articleNo Access

          Industry Watch

            Eli Lilly Reports Strong Growth in China.

            Drop in Profits for Shanghai Drug Distribution Companies.

            Largest Antibiotics Production Plant in Southwest China Established.

            Guangzhou Jiuzhoutong Medicine Logistics Center in Operation.

            Beijing Yinjian Enterprise Enters Drug Retail Sector.

            Zhejiang Pharmaceutical First in Vitamin E Production.

            Luye Pharmaceutical’s Aescinate Granted US Patent.

            Drug Molecular Design Center Set Up in Beijing.

            Strand Genomics Licences Soochika.

            Transgene Plans a Merger with Saket.

            Alembic Acquires Yutopar from Solvay.

            Doosan’s New Manufacturing Plant in Beijing.

            CordLife Launches Peripheral Blood Stem Cell Processing and Banking Services.

          • articleNo Access

            Industry Watch

              EpiTan Annual Results.

              Wuxi Jiante Pharma Partners Roche Vitamin to Launch New Health Supplement.

              Shiyao Group Zhongnuo Pharma Established to Produce Antibiotics.

              Shanghai Lvgu Group to Produce New Anti-Cancer Drug Salvicine.

              Shaanxi Dongsheng Group Establishes Life Science Park in Jiangsu Qidong.

              Chongqing 999 Pharma Sprout from Fuling Yuyi Pharma Restructuring.

              Yunnan Yunyao Pharma Established.

              Hainan Hailiang Biotech Gearing Up for Anti-Cancer Drug Vinorelbine Production.

              Biocon's Strategic Expansion.

              Olanzapine Dispute between Dr. Reddy's Laboratory and Eli Lilly Resolved.

              Protemix Receives Financial Support from New Zealand Government.

              Media Cybernetics Secures Distribution Agreement with Olympus Optical.

              Alchemgen to Raise Fund for Anti-Cancer Drug Development in Taiwan.

              Optimer's Taiwan Subsidiary to Import Overseas Drugs.

              Sun Ten Pharmaceutical to Venture into the European and China Markets.

            • articleNo Access

              Global Development

                Was it SARS?

                Eli Lilly's Bid to Curb Tuberculosis.

                Fountain-Pen Nanochemistry Enables Writing of Microscipic Patterns of Protein.

              • articleNo Access

                Industry Watch

                  Alliance between AGT Biosciences and Starpharma.

                  First Australian Biotech Company to List on HKSE.

                  Breakthrough in Transdermal Drug Discovery Technology.

                  Acrux Licenses MDTS Technology to Eli Lilly got Animal Health Products.

                  Biota Secures SARS Testing Agreement with US Government Research Agencies.

                  SysArris in Bio Partnering Europe 2003.

                  Shantha Bio to Launch Streptokinase by Year-end.

                  Lupin Receives US FDA Approval to Launch Ceftriaxone.

                  MerLion Pharma Collaborates with Schering-Plough in Drug Discovery Research.

                  Quest Pharmaceutical Sets up Taiwanese Subsidiary.

                  BenQ to Invest in Nanjing's Medical Facilities.

                • articleNo Access

                  Industry Watch

                    SLT's Hepatitis A Diagnostic Kits under Licensing Evaluation.

                    First Logistics and Delivery Center in Shenzhen Launched.

                    China's First Anti-AIDS Intermediates Production Facility.

                    Eli Lilly Dispersible Prozac Tablets Available in China.

                    Micro Labs Expands Manufacturing Capacities.

                    Paradigm Sets up Subsidiary in Singapore.

                    TaiGen Receives Funding for Anti-SARS Research.

                    Xcyte Therapies Partners Taiwan Cell Therapy in Cancer Technology.

                  • articleNo Access

                    Industry Watch

                      Clinigene and SCIREX Cooperate on Global Clinical Trials.

                      CSL Announces New Share Buyback.

                      International Alliance Between ChemGenex and Stragen Pharma.

                      Mayne Pharma Expands in Europe.

                      Bausch & Lomb Acquires Shandong Chia Tai Freda Pharma.

                      Eli Lilly Collaborates with Taisho Pharma.

                      Pingchuan Signs Purchase and Sales Agreement with Sinopharm.

                      Vietnam to Begin Animal Testing of VIRA 38.

                      NIRS and Toshiba Medical Systems Develop a New 4-D Medical Imaging Device.

                      Medipost—First Biotech Company to List on the Korea Stock Exchange.

                      Korea Plans First Stem Cell Hospital.

                      Bio-Diagnostic Commercializes Rapid Diagnostic Kits for Infectious Diseases.

                      INS Bioscience Expands to China, US and West Asia.

                      Neuren Teams up with Walter Reed Army Institute of Research.

                      Paradigm Signs Licensing and Collaborating Deal with Ortho-McNeil.

                      Paradigm and Takeda Enter Into CNS Therapeutics Alliance.

                    • articleNo Access

                      People

                        Dr. David T Wong.